USPTO serial 79186202
LIVANOVA
Reviewed by CopyMark Law Group
Reg. 5061655Status 739Renewal
- Filing date
- Status date
- Registration date
- Oct 18, 2016
- Examiner
- LEASER, ANDREW C
- Law office
- GENERIC WEB UPDATE
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LIVANOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Danielle I. Mattessich
Danielle I. Mattessich MERCHANT & GOULD P.C.P.O. Box 2910Minneapolis, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Apparatus for recording, transmission or reproduction of sound or images; ] calculating machines, data processing equipment, computers; [ computer software for medical purposes used to analyze electrocardiographic (ECG) signals recorded with an ambulatory ECG recorder; computer software used to program heart pacemakers and defibrillators; ] software for extracorporeal circulation operation data management during cardiac surgery operations used on heart-lungs machines in the operating rooms; all the above for medical and surgical use | ACTIVE | — |
| 010 | [ Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic hip prosthesis, orthopedic fixation device used in orthopedic transplant and/or implant surgery, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials; medical devices involved in the field of cardiac surgery solutions, namely, aortic devices, namely, suture less valve for aortic valve replacement, mechanical heart valve prostheses, mechanical prosthesis for aortic root replacement, supra-annular aortic valve; mitral devices, namely, rigid annuloplasty rings; ] perfusion devices, namely, heart monitors and respiration monitors, and replacements parts for the monitors, perfusion systems comprised of power supply units, roller pumps and monitoring device for perfusion systems, and replacement parts for perfusion systems; cannulae for minimally invasive cardiac surgery; [ pediatric devices, namely, ] pediatric valves, pediatric hollow fiber oxygenator, pediatric arterial filters; [ medical devices involved in the field of cardiac rhythm management solutions, namely, bradyarrhythmia assessment devices, tachyarrhythmia assessment devices, heart failure assessment devices; arrhythmia assessment devices; electrophysiology electrodes and diagnostic catheters; medical devices involved in the field of neuromodulation, namely, medical system and apparatus consisting of a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves, medical system and apparatus consisting of a non-implantable modulating frequency generator and implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management, namely, patient stimulators for auricular and peri-auricular peripheral nerve in the field of neuromodulation therapy, implantable batteries for neuromodulation, implantable neuromodulation device that delivers a high frequency electrical signal for use in chronic pain, motor control, spasticity, and autonomic nervous system applications; medical implants including programmable pulse generators and leads used for the control of neurological disorders and neurological and muscle stimulators and related control equipment; radio frequency programming and telemetry decoders for use with medical implants; medical devices for the treatment of refractory epilepsy and treatment-resistant depression; aortic valve comprised of artificial materials for implantation; aortic clamps; mechanical heart valves comprised of artificial materials for implantation; mitral valves comprised of artificial materials for implantation; mitral rings and bands comprised of artificial materials for degenerative mitral valve regurgitation and myxomatous degeneration; minibands comprised of artificial materials for degenerative and functional mitral regurgitation and for tricuspid regurgitation; tricuspid bands comprised of artificial materials for tricuspid valve regurgitation; mitral and tricuspidal atrial blades retractors; ] medical apparatus, namely, integrated system heart lung machine disposable to optimize the extra corporeal circulation; oxygenators; patient membrane oxygenator and structural parts therefor; centrifugal blood pump system to improve outcomes for traditional bypass, mini-bypass and kinetic assist venous drainage; portable cardiopulmonary bypass systems; portable systems for extracorporeal circulation and autotransfusion; monitors for blood parameters in ECC (extracorporeal circulation); perfusion tubing systems; medical devices, namely, endoscopic vessel harvesting system and accessories sold therewith as a unit; aortic arch cannulae; venous return cannulae; suction wands and intracardiac suckers in the nature of wound suction apparatus; [ pericardiac sump pumps; ] femoral arterial (FA) and femoral venous (FV) cannulae for cannulation of femoral vessels; cannulae for pediatric cardiac surgery; [ cardiac pacemakers; defibrillators; vascular prostheses; vascular repairing parts, namely, aortic bioprosthesis heart valves, aortic pericardial heart valves, coronary bypass, implantable cardioverter-defibrillators; medical apparatus for cardiac resynchronization; accelerometer sensor as a feature of a pacemaker or defibrillator for analyzing the rhythm and range of mechanical cardiac events; medical device intended for the digital recording of multi-lead and multi-day holter data; ] all the above for medical and surgical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 18, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 29, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 29, 2023 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 24, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Oct 24, 2022 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| Oct 24, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 17, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 18, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 4, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 4, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 4, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 4, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 4, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 31, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| May 4, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 3, 2017 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 14, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 13, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 18, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 2, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 2, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 13, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 13, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 13, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 25, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 10, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 25, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 25, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 20, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 30, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 26, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 22, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 21, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |